IP Library Granted Patent US 7,531,355
Granted Patent B2
US 7,531,355 · App. 11/192,753 · Granted May 12, 2009

Methods and compositions for smooth muscle reconstruction

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,531,355
App. No.
11/192,753
Granted
May 12, 2009
Kind
B2
Abstract

This invention also provides a purified or isolated population of ADSCs that can differentiate into a cell of the leiomyogenic lineage, e.g., smooth muscle or skeletal muscle. In yet another aspect, the population additionally can be differentiated into a lineage selected from the group consisting of osteogenic, adipogenic, chondrogenic, myogenic and neuronal. This invention further provides a composition comprising a substantially homogeneous expanded population of smooth muscle cells. This invention provides a composition comprising a substantially homogeneous expanded population of skeletal muscle cells. Also provided herein is an isolated composition comprising a purified adipose-derived stem cell (ADSC) or progeny of said ADSC and an effective amount of laminin or heparin, effective to induce leiomyogenic differentiation. Diagnositic and therapeutic uses for these compositions are provided herein.

Claims (9)

1. A method for inducing leiomyogenic differentiation of a purified adipose-derived stem cell (ADSC) comprising contacting the purified ADSC in vitro with an effective amount of a source of heparin thereby inducing leiomyogenic differentiation.

2. The method of claim 1 , wherein the purified ADSC is obtained from a source selected from the group consisting of processed lipoaspirate, a substantially homogeneous population of ADSC, a clonal population of ADSC and a single, isolated ADSC.

3. The method of claim 1 or 2 , further comprising contacting the purified ADSC with a source of laminin or a growth factor.

4. The method of claim 1 or 2 , further comprising transplanting said ADSC into a tissue in a subject.

5. The method of claim 3 , further comprising transplanting said ADSC into a tissue in a subject.

6. The method of claim 4 , wherein the tissue comprises the gerintourinary tract of the subject.

7. The method of claim 5 , wherein the tissue comprises the gerintourinary tract of the subject.

8. The method of claim 6 , wherein the tissue comprises the bladder or urethra of the subject.

9. The method of claim 7 , wherein the tissue comprises the bladder or urethra of the subject.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 16, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024701/0754 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Dec 18, 2008
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022003/0412 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2005
From: RODRIGUEZ, LARISSA V.; WU, BEN
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 016624/0093 →
Continuity (1)
Related Publication 20070025972A1 · Feb 1, 2007